Published in Women's Health Weekly, January 8th, 2009
"CPTI I and MMC were administered on days I and 15 by intravenous infusion, while 5-FU was given on days 3 to 7. This regimen was repeated after 5 weeks. Four escalating dose levels were carried out (CPT-11/MMC: 120/5. 120/6, 150/6, and 150/7 mg/m(2): 5-FU 600 mg/m(2) fixed)....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.